• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ZTA-P-30-155-W1
Device Problems Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Paralysis (1997)
Event Date 01/23/2024
Event Type  Injury  
Manufacturer Narrative
Manufacturer ref# (b)(4) blank fields on this form indicate the information is unknown or unavailable.G4) similar to device under pma/510(k) p140016 investigation is still in progress this report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
Description of event according to initial reporter: patient anatomy before surgery and at the time of failure:although not numerous, some degree of mural thrombus was observed in the descending aorta.Devices used: zta-p-30-155-w1 (lot# e4247197) - approached from the right femoral artery to the descending aorta zta-pt-40-36-217-w1 (lot# e4182403) - approached from the right femoral artery to the aortic arch this was a case of 2-debranching tevar.The procedure was completed without any problems using standard tevar procedures.Immediately after the surgery, the movement of both lower limbs was poor, however, at this point, it was unclear whether the poor movement of both lower limbs was due to spinal cord ischemia due to the scattering of mural thrombi, whether it was simply because it took time to wake up from anesthesia, or whether it was due to his pre-existing condition, cerebral infarction.And the patient did not recover even after 1 week after the surgery.An mri scan revealed scattered embolization around th6 and 7 (thoracic spines 6 and 7).Patient outcome.The patient was left with paralysis in both lower limbs as an sequela.Future plans for additional treatment are unknown.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Manufacturers ref# (b)(4).After investigation the event for this (b)(4) is no longer reportable.Summary of investigational findings: an 81-year-old male patient underwent 2-debranching tevar (thoracic endovascular aortic repair), where zta-p-30-155-w1 was approaching to the descending aorta and zta-pt-40-36-217-w1 to the aortic arch.Patient anatomy before surgery and at the time of failure was reported with some degree of mural thrombus in the descending aorta.The procedure was completed without any problems.Immediately after the surgery, the movement of both lower limbs was poor, however, at this point, it was unclear whether the poor movement of both lower limbs was due to spinal cord ischemia due to the scattering of mural thrombus, whether it was simply because it took time to wake up from anesthesia, or whether it was due to his pre-existing condition, cerebral infarction.And the patient did not recover even after 1 week after the surgery.An mri scanning (magnetic resonance imaging) revealed scattered embolization around th6 and th7 (thoracic spines 6 and 7).The patient was left with paralysis in both lower limbs as an sequela.Future plans for additional treatment are unknown.No imaging was provided for the investigation.Paralysis is listed as a potential adverse effect in the instructions for use (ifu).Based on the reported information an exact cause cannot be established.However, as nothing indicates that the event is related to fault conditions of the device or abnormal use of the device, the event is assessed to be a side effect, which potentially could be related to procedure and patient medical condition.It is noted that zta is used in 2-debranching tevar.According to the ifu, the zenith alpha thoracic endovascular graft is designed to treat proximal aortic necks (distal to either the left subclavian or left common carotid artery) of at least 20 mm in length.Additional proximal aortic neck length may be gained by covering the left subclavian artery (with or without discretionary transposition) when necessary to optimize device fixation and maximize aortic neck length.Cook medical will continue to monitor for similar events.This report is required by the fda under 21cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
Manufacturer (Section G)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA   4632
Manufacturer Contact
alex rahbek
sandet 6
bjaeverskov 4632
DA   4632
56868686
MDR Report Key18738339
MDR Text Key335743303
Report Number3002808486-2024-00033
Device Sequence Number1
Product Code MIH
UDI-Device Identifier10827002449463
UDI-Public(01)10827002449463(17)250413(10)E4247197
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberZTA-P-30-155-W1
Device Lot NumberE4247197
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/08/2024
Initial Date FDA Received02/20/2024
Supplement Dates Manufacturer Received03/14/2024
Supplement Dates FDA Received03/20/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/13/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age81 YR
Patient SexMale
-
-